BMJ Best Practice

参考文献

关键文献

World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. 2011 [internet publication].

World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. 2009 [internet publication].

Guo C, Zhou Z, Wen Z, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017 Jul 12;7:317.

Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012 Apr 12;366(15):1423-32.

Hadinegoro SR, Arredondo-García JL, Capeding MR, et al. Efficacy and long-term safety of a dengue vaccine inregions of endemic disease. N Engl J Med. 2015 Sep 24;373(13):1195-206.

Centers for Disease Control and Prevention. Clinical guidance: dengue virus. September 2014 [internet publication].

参考文章

1.  World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. 2011 [internet publication].

2.  World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. 2009 [internet publication].

3.  Barniol J, Gaczkowski R, Barbato EV, et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis. 2011 Apr 21;11:106.

4.  Trunfio M, Savoldi A, Viganò O, et al. Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern. Infection. 2017 Feb;45(1):1-10.

5.  World Health Organization. Dengue and severe dengue. September 2018 [internet publication].

6.  Sharp TM, Perez-Padilla J, Waterman SH. Dengue. In: Brunette GW, ed. CDC Yellow Book 2018: Health Information for International Travel. New York, NY: Oxford University Press; 2017.

7.  Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 1997 Aug;176(2):313-21.

8.  Guzman MG, Kouri G. Dengue and dengue haemorrhagic fever in America: lessons and challenges. J Clin Virol. 2003 May;27(1):1-13.

9.  Teixeira MG, Barreto M. Diagnosis and management of dengue: clinical review. BMJ. 2009 Nov 18;339:b4338.

10.  Pan American Health Organization. Reported cases on dengue fever in the Americas by country or territory. February 2018 [internet publication].

11.  Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008 Nov;92(6):1377-90.

12.  Public Health England. Dengue fever: annual report. November 2015 [internet publication].

13.  Guo C, Zhou Z, Wen Z, et al. Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2017 Jul 12;7:317.

14.  Soo KM, Khalid B, Ching SM, et al. Meta-analysis of dengue severity during infection by different dengue virus serotypes in primary and secondary infections. PLoS One. 2016 May 23;11(5):e0154760.

15.  Halsted SB. Epidemiology of dengue and dengue hemorrhagic fever. In: Gubler DJ and Kuno G, eds. Dengue and dengue haemorrhagic fever. New York, NY: CAB International; 1997:45-60.

16.  Webster DP, Farrar J, Rowland-Jones S. Progress towards dengue vaccine. Lancet Infect Dis. 2009 Nov;9(11):678-87.

17.  Pichainarong N, Mongkalangoon N, Kalyanarooj S, et al. Relationship between body size and severity of dengue haemorrhagic fever among children aged 0-14 years. South East J Trop Med Public Health. 2006 Mar;37(2):283-8.

18.  Guzman MG, Kouri GP, Bravo J, et al. Dengue haemorrhagic fever in Cuba 1981, retrospective seroepidemiological study. Am J Trop Med Hyg. 1990 Feb;42(2):179-84.

19.  Chen LH, Wilson ME. Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect Dis. 2004 Sep 15;39(6):e56-60.

20.  Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion. 2012 Aug;52(8):1657-66.

21.  Sabino EC, Loureiro P, Lopes ME, et al; International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis. 2016 Mar 1;213(5):694-702.

22.  Stephenson JR. Understanding dengue pathogenesis: implication for vaccine design. Bull World Health Organ. 2005 Apr;83(4):308-14.

23.  Whitehorn J, Simmons CP. The pathogenesis of dengue. Vaccine. 2011 Sep 23;29(42):7221-8.

24.  Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected tissue, by immunohistochemistry and in situ hybridation. J Infect Dis. 2004 Apr 15;189(8):1411-8.

25.  Weerakoon KG, Kularatne SA, Edussuriya DH, et al. Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009. BMC Res Notes. 2011 Jul 29;4:268.

26.  Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with development of dengue haemorrhagic fever. J Infect Dis. 2002 Oct 15;186(8):1165-8.

27.  Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012 Apr 12;366(15):1423-32.

28.  Hajra A, Bandyopadhyay D, Hajra SK. Zika virus: a global threat to humanity: a comprehensive review andcurrent developments. N Am J Med Sci. 2016 Mar;8(3):123-8.

29.  Villamil-Gómez WE, González-Camargo O, Rodriguez-Ayubi J, et al. Dengue, chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health. 2016 Sep-Oct;9(5):684-6.

30.  Magalhães BM, Siqueira AM, Alexandre MA, et al. P. vivax malaria and dengue fever co-infection: a cross-sectional study in the Brazilian Amazon. PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3239.

31.  Santos AC, de Moura EL, Ferreira JM, et al. Meta-analysis of the relationship between TNF-α (-308G/A) and IL-10 (-819C/T) gene polymorphisms and susceptibility to dengue. Immunol Invest. 2017 Feb;46(2):201-20.

32.  Pabalan N, Chaisri S, Tabunhan S, et al. Associations of tumor necrosis factor-α-308 polymorphism with dengue infection: a systematic review and meta-analysis. Acta Trop. 2017 Sep;173:17-22.

33.  Halstead SB. Dengue. Lancet. 2007 Nov 10;370(9599):1644-52.

34.  Gamble J, Bethell D, Day NP, et al. Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci [Lond]. 2000 Feb;98(2):211-6.

35.  Kularatne SA, Patirage MM, Pathirage PV, et al. Cardiac complication of a dengue fever outbreak of Sri Lanka, 2005. Trans R Soc Trop Med Hyg. 2007 Aug;101(8):804-8.

36.  Kularatne SA, Pathirage MM, Gunasena S. A case series of dengue fever with altered consciousness and electroencephalogram changes in Sri Lanka. Trans R Soc Trop Med Hyg. 2008 Oct;102(10):1053-4.

37.  Gulati S, Maheshwari A. Atypical manifestations of dengue. Trop Med Int Health. 2007 Sep;12(9):1087-95.

38.  Pouliot SH, Xiong X, Harille RM, et al. Maternal dengue and pregnancy outcomes: a systemic review. Obstet Gynecol Surv. 2010 Feb;65(2):107-18.

39.  Paixão ES, Teixeira MG, Costa MDCN, et al. Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. Lancet Infect Dis. 2016 Jul;16(7):857-65.

40.  Adam I, Jumaa AM, Elbashir HM, et al. Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan. Virol J. 2010 Jul 13;7:153.

41.  Xiong YQ, Mo Y, Shi TL, et al. Dengue virus infection during pregnancy increased the risk of adverse fetal outcomes? An updated meta-analysis. J Clin Virol. 2017 Sep;94:42-9.

42.  Bravo JR, Guzmán MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factor for dengue haemorrhagic fever/dengue shock syndrome. Trans R Soc Trop Med Hyg. 1987;81(5):816-20.

43.  Toledo J, George L, Martinez E, et al. Relevance of non-communicable comorbidities for the development of the severe forms of dengue: a systematic literature review. PLoS Negl Trop Dis. 2016 Jan 4;10(1):e0004284.

44.  Anders KL, Nguyet NM, Chau NV, et al. Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg. 2011 Jan;84(1):127-34.

45.  Thisyacorn U, Nimmannitya S. Nutritional status of children with dengue haemorrhagic fever. Clin Infect Dis. 1993 Feb;16(2):295-7.

46.  Kalayanarooj S, Nimmannitya S. Is dengue severity related to nutritional status? South East J Trop Med Public Health. 2005 Mar;36(2):378-84.

47.  Patel RV, Shaeer KM, Patel P, et al. EPA-registered repellents for mosquitoes transmitting emerging viral disease. Pharmacotherapy. 2016 Dec;36(12):1272-80.

48.  Baldacchino F, Caputo B, Chandre F, et al. Control methods against invasive Aedes mosquitoes in Europe: a review. Pest Manag Sci. 2015 May 21. Pest Manag Sci. 2015 Nov;71(11):1471-85.

49.  Andersson N, Nava-Aguilera E, Arosteguí J, et al. Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial. BMJ. 2015 Jul 8;351:h3267.

50.  World Health Organization. Immunization, vaccines and biologicals: questions and answers on dengue vaccines. April 2018 [internet publication].

51.  Hadinegoro SR, Arredondo-García JL, Capeding MR, et al. Efficacy and long-term safety of a dengue vaccine inregions of endemic disease. N Engl J Med. 2015 Sep 24;373(13):1195-206.

52.  Godói IP, Lemos LL, de Araújo VE, et al. CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety. J Comp Eff Res. 2017 Mar;6(2):165-80.

53.  World Health Organization. Immunization, vaccines and biologicals: revised SAGE recommendation on use of dengue vaccine. April 2018 [internet publication].

54.  Torresi J, Ebert G, Pellegrini M. Vaccines licensed and in clinical trials for the prevention of dengue. Hum Vaccin Immunother. 2017 May 4;13(5):1059-72.

55.  Premaratne R, Pathmeswaran A, Amarasekara ND, et al. A clinical guide for early detection of dengue fever and timing of investigations to detect patients likely to develop complications. Trans R Soc Trop Med Hyg. 2009 Feb;103(2):127-31.

56.  Ministry of Health, Sri Lanka. Guidelines on management of dengue fever and dengue haemorrhagic fever in children and adolescents: revised and expanded edition. November 2012 [internet publication].

57.  Kalayanarooj S, Nimmanitya S, Suntayakorn S, et al. Can doctors make an accurate diagnosis of dengue infection at an early stage? Dengue Bull. 1999;23:1-9.

58.  Sawasdivorn S, Vibulvattanakit S, Sasavatpakdee M, et al. Efficacy of clinical diagnosis of dengue fever in paediatric age groups as determined by WHO case definition 1997 in Thailand. Dengue Bull. 2001;25:56-64.

59.  Hunsperger EA, Muñoz-Jordán J, Beltran M, et al. Performance of dengue diagnostic tests in a single-specimen diagnostic algorithm. J Infect Dis. 2016 Sep 15;214(6):836-44.

60.  Lima Mda R, Nogueira RM, Schatzmayr HG, et al. Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl Trop Dis. 2010 Jul 6;4(7):e738.

61.  Rasmussen SA, Jamieson DJ, Honein MA, et al. Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med. 2016 May 19;374(20):1981-7.

62.  Centers for Disease Control and Prevention. New CDC laboratory test for Zika virus authorized for emergency use by FDA. March 2016 [internet publication].

63.  Centers for Disease Control and Prevention. Revised diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories [memorandum]. February 2016 [internet publication].

64.  Gyurech D, Schilling J, Schmidt-Chanasit J, et al. False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland. Swiss Med Wkly. 2016 Feb 9;146:w14296.

65.  Go YY, Rajapakse RP, Kularatne SA, et al. A pan-dengue virus reverse transcription-insulated isothermal polymerase chain reaction (RT-iiPCR) assay intended for point-of-need diagnosis of dengue infection using POCKITTM Nucleic Acid Analyzer. J Clin Microbiol. 2016 Jun;54(6):1528-35.

66.  Pan American Health Organization; World Health Organization. Tool for the diagnosis and care of patients with suspected arboviral diseases. March 2017 [internet publication].

67.  Nguyen MT, Ho TN, Nguyen VV, et al. An evidence-based algorithm for early prognosis of severe dengue in the outpatient setting. Clin Infect Dis. 2017 Mar 1;64(5):656-63.

68.  Centers for Disease Control and Prevention. CDC DENV-1-4 real-time RT-PCR assay for detection and serotype identification of dengue virus. July 2013 [internet publication].

69.  Kularatne SA, Gihan MC, Weerasinghe SC, et al. Concurrent outbreaks of Chikungunya and Dengue fever in Kandy, Sri Lanka, 2006-07: a comparative analysis of clinical and laboratory features. Postgrad Med J. 2009 Jul;85(1005):342-6.

70.  Kularatne SAM, Weerasinghe SC, Gihan C, et al. Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in Sri Lanka in 2007: a longitudinal cohort study. J Trop Med. 2012;2012:639178.

71.  Walker DH, Raoult D. Rickettsia rickettsi and other spotted fever group rickettsiae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed, v2. New York, NY: Churchill Livingstone; 2000:2035-42.

72.  Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global public health problem. J Biosci. 2008 Nov;33(4):557-69.

73.  Centers for Disease Control and Prevention. Clinical guidance: dengue virus. September 2014 [internet publication].

74.  Ashley EA. Dengue fever. Trends Anaesth Crit Care. 2011;1:39-41.

75.  Dung NM, Day NP, Tam DT, et al. Fluid replacement in dengue shock syndrome: randomized, double-blind comparison of four intravenous fluid regimens. Clin Infect Dis. 1999 Oct;29(4):787-94.

76.  Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001 Jan 15;32(2):204-13.

77.  Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005 Sep 1;353(9):877-89.

78.  Ministry of Health, Sri Lanka. Guidelines on management of dengue fever and dengue haemorrhagic fever in adults: revised and expanded edition. November 2012 [internet publication].

79.  Rajapakse S. Corticosteroids in the treatment of dengue illness. Trans R Soc Trop Med Hyg. 2009 Feb;103(2):122-6.

80.  Lye DC, Archuleta S, Syed-Omar SF, et al. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017 Apr 22;389(10079):1611-8.

81.  Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2015 Aug 14;(8):CD007798.

82.  Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96.

83.  McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.

84.  Smith RN, Nolan JP. Central venous catheters. BMJ. 2013 Nov 11;347:f6570.

85.  Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.

86.  Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2015 [internet publication].

87.  Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78.

88.  Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91.

89.  Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.

90.  Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4.

91.  Zhang F, Kramer CV. Corticosteroids for dengue infection. Cochrane Database Syst Rev. 2014;(7):CD003488.

92.  Tam DT, Ngoc TV, Tien NT, et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis. 2012;55:1216-1224.

93.  Noble CG, Chen YL, Dong H, et al. Strategies for development of dengue virus inhibitors. Antiviral Res. 2010;85:450-462.

94.  Nguyen NM, Tran CN, Phung LK, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 2013;207:1442-1450.

95.  Whitehorn J, Nguyen CVV, Khanh LP, et al. Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2016;62:468-476.

96.  Kularatne SA, Imbulpitiya IV, Abeysekera RA, et al. Extensive haemorrhagic necrosis of liver is an unpredictable fatal complication in dengue infection: a postmortem study. BMC Infect Dis. 2014 Mar 14;14:141.

97.  Mallhi TH, Sarriff A, Adnan AS, et al. Dengue-induced acute kidney injury (DAKI): a neglected and fatal complication of dengue viral infection--a systematic review. J Coll Physicians Surg Pak. 2015 Nov;25(11):828-34.

98.  Kamel MG, Nam NT, Han NHB, et al. Post-dengue acute disseminated encephalomyelitis: a case report and meta-analysis. PLoS Negl Trop Dis. 2017 Jun 30;11(6):e0005715.

使用此内容应接受我们的免责声明。